Cargando…

PS77. No different treatment outcome of Mirtazapine with Major Depression Patients with MAOA Gene Polymorphism

Detalles Bibliográficos
Autores principales:	Chien, Chia Chang, Changchien, Te Chang, Kao, Wei Tsung, Yen, Yung-Chieh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616674/ http://dx.doi.org/10.1093/ijnp/pyw043.077

Ejemplares similares

PS88. Association between Alu insertion/deletion polymorphism on the tPA gene and mirtazapine response in Koreans with major depression
por: Kim, Daseul, et al.
Publicado: (2016)

PS213. Pharmacokinetics of mirtazapine and its hydroxylated metabolite in Japanese psychiatric patients treated with mirtazapine
por: Watanabe, Takashi, et al.
Publicado: (2016)

An association study between various monoamine transporter gene polymorphisms and treatment response to mirtazapine in major depression
por: Choi, Hong
Publicado: (2010)

High Risk of Depressive Disorders in Patients With Gout: A Nationwide Population-Based Cohort Study
por: Changchien, Te-Chang, et al.
Publicado: (2015)

Association of the MAOA promoter uVNTR polymorphism with suicide attempts in patients with major depressive disorder
por: Lung, For-Wey, et al.
Publicado: (2011)

Roles of Hostility and Depression in the Association between the MAOA Gene Polymorphism and Internet Gaming Disorder
por: Yen, Ju-Yu, et al.
Publicado: (2021)

PS76. Effect of antidepressant therapy on white matter in patients with first-episode major depressive disorder
por: Lee, Chun-Te, et al.
Publicado: (2016)

Psychiatric symptoms and leptin in obese patients who were bariatric surgery candidates
por: Changchien, Te-Chang, et al.
Publicado: (2015)

PS163. Serotonin Transporter Polymorphism in Severe Major Depressive Disorder in Indonesia
por: Arlisa, Wulandari, et al.
Publicado: (2016)

The Joint Effects of Body Mass Index and MAOA Gene Polymorphism on Depressive Symptoms
por: Liu, Yangyang
Publicado: (2015)

PS50. The serum oxytocin levels among major depressive and bipolar II disorder
por: Lien, Yueh-Ju, et al.
Publicado: (2016)

Longitudinal Association of Universal Screening and Treatment for Major Depressive Disorder with Survival in Cancer Patients
por: Yen, Yung-Chieh, et al.
Publicado: (2022)

MAOA uVNTR Genetic Variant and Major Depressive Disorder: A Systematic Review
por: Castro Gonçalves, Ana Beatriz, et al.
Publicado: (2022)

PS129. Low TNFAIP3 was normalized with antidepressant in patients with major depressive disorder
por: Hung, Yi-Yung
Publicado: (2016)

Regional cortical thinning of the orbitofrontal cortex in medication-naïve female patients with major depressive disorder is not associated with MAOA-uVNTR polymorphism
por: Won, Eunsoo, et al.
Publicado: (2016)

Mirtazapine overdose is unlikely to cause major toxicity
por: Berling, I., et al.
Publicado: (2014)

PS192. A study of tryptophan, kynurenine and serotonin transporter in first-episode, drug-naïve patients with major depressive disorder
por: Chiu, Yen-Chen, et al.
Publicado: (2016)

The influence of concentration of micro-rna hsa-mir-370-3p and CYP2D6*4 on equilibrium concentration of mirtazapine in patients with major depressive disorder
por: Zastrozhin, M., et al.
Publicado: (2021)

Mirtazapine-induced psychosis on a young patient with severe malnutrition
por: Sollano, R. T. E., et al.
Publicado: (2023)

PS181. A study of hippocampal volumes in first-episode, drug-naïve major depression disorder.
por: Wang, Ying-Chih, et al.
Publicado: (2016)

A COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF MIRTAZAPINE VERSUS AMITRIPTYLINE IN THE TREATMENT OF MAJOR DEPRESSION
por: Mathur, Anand, et al.
Publicado: (2002)

Identifying predictive clinical characteristics of the treatment efficacy of mirtazapine monotherapy for major depressive disorder
por: Tsutsumi, Takahiro, et al.
Publicado: (2016)

PS90. Differences in hypochondriasis between Korean and American outpatients with major depressive disorder
por: Kim, Jiyeon, et al.
Publicado: (2016)

PS203. The correlation between high-density lipoprotein and serum brain-derived neurotrophic factor levels in patients with major depressive disorder
por: Yang, Meng Fan, et al.
Publicado: (2016)

Mirtazapine Creating “Miracles” in Psychotic Depression With Catatonia
por: Patel, Rikinkumar S, et al.
Publicado: (2020)

Emotional stability is associated with the MAOA promoter uVNTR polymorphism in women
por: Rodríguez‐Ramos, Ángel, et al.
Publicado: (2019)

PS161. Association study of polymorphism in the serotonin transporter gene promoter, methylation profiles, and expression in patients with major depressive disorder
por: Iga, Junichi
Publicado: (2016)

PS96. The change of prescribing patterns for inpatients of major depressive disorder
por: Kim, Hyeri, et al.
Publicado: (2016)

PS169. Disruption of relationship between serotonin transporter and hippocampal volumes in first-episode drug-naïve major depressive disorder
por: Kao, Zih-Kai, et al.
Publicado: (2016)

Efficacy and safety of add on low-dose mirtazapine in depression
por: Matreja, Prithpal S., et al.
Publicado: (2012)

Cell Model of Depression: Reduction of Cell Stress with Mirtazapine
por: Correia, Ana Salomé, et al.
Publicado: (2022)

A Functional Polymorphism of the MAOA Gene Modulates Spontaneous Brain Activity in Pons
por: Lei, Hui, et al.
Publicado: (2014)

The (7,7) optics at CERN PS
por: Serluca, M, et al.
Publicado: (2017)

PS195. Reduced cerebrospinal fluid ethanolamine concentration in major depressive disorder
por: Ogawa, Shintaro, et al.
Publicado: (2016)

Resolution of Pregabalin and Mirtazapine Associated Restless Legs Syndrome by Bupropion in a Patient with Major Depressive Disorder
por: Park, Young-Min, et al.
Publicado: (2009)

PS46. Distinct and shared morphometric biomarkers of depressed individuals with bipolar disorder and major depressive disorder
por: Matsuo, Koji, et al.
Publicado: (2016)

MAOA Influences the Trajectory of Attentional Development
por: Lundwall, Rebecca A., et al.
Publicado: (2016)

PS232. Influence of alexithymia on the prognosis of patients with major depression treated using pharmacotherapy.
por: Mantani, Tomoyuki, et al.
Publicado: (2016)

PS75. Psychopharmacoepidemiology of Major Depressive Disorder in European Tertiary Psychiatric Treatment Centers
por: Bartova, Lucie, et al.
Publicado: (2016)

The effects of beta2 adrenergic receptor gene polymorphism in lipid profiles
por: Kao, Wei-Tsung, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_j4vljjr8amv07hgggqb6puvj1e